Bausch Health Companies Inc. [NYSE: BHC] traded at a low on 02/24/23, posting a -2.84 loss after which it closed the day’ session at $9.57. The company report on February 23, 2023 that Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Fourth-Quarter revenues of $2.2 billion, flat reported, up 4% organic1.
Full-Year revenues of $8.1 billion, down 4% reported, up 2% organic1.
The results of the trading session contributed to over 12061182 shares changing hands. Over the past one week, the price volatility of Bausch Health Companies Inc. stands at 9.14% while the volatility over the past one month is 6.26%.
The market cap for BHC stock reached $3.56 billion, with 362.60 million shares outstanding and 344.64 million shares in the current float. Compared to the average trading volume of 5.88M shares, BHC reached a trading volume of 12061182 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Bausch Health Companies Inc. [BHC]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BHC shares is $12.14 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BHC stock is a recommendation set at 2.80. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Truist have made an estimate for Bausch Health Companies Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on July 29, 2022. While these analysts kept the previous recommendation, RBC Capital Mkts raised their target price from $12 to $5. The new note on the price target was released on July 29, 2022, representing the official price target for Bausch Health Companies Inc. stock.
The Average True Range (ATR) for Bausch Health Companies Inc. is set at 0.57, with the Price to Sales ratio for BHC stock in the period of the last 12 months amounting to 0.44.
How has BHC stock performed recently?
Bausch Health Companies Inc. [BHC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 6.69. With this latest performance, BHC shares gained by 14.20% in over the last four-week period, additionally plugging by 81.59% over the last 6 months – not to mention a drop of -58.23% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BHC stock in for the last two-week period is set at 64.29, with the RSI for the last a single of trading hit 65.57, and the three-weeks RSI is set at 62.80 for Bausch Health Companies Inc. [BHC]. The present Moving Average for the last 50 days of trading for this stock 7.66, while it was recorded at 9.29 for the last single week of trading, and 7.52 for the last 200 days.
Bausch Health Companies Inc. [BHC]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Bausch Health Companies Inc. [BHC] shares currently have an operating margin of +17.12 and a Gross Margin at +55.95. Bausch Health Companies Inc.’s Net Margin is presently recorded at -2.77.
Bausch Health Companies Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.80 and a Current Ratio set at 1.10.
Earnings analysis for Bausch Health Companies Inc. [BHC]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BHC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Bausch Health Companies Inc. go to 2.60%.
Insider trade positions for Bausch Health Companies Inc. [BHC]
There are presently around $2,759 million, or 66.80% of BHC stock, in the hands of institutional investors. The top three institutional holders of BHC stocks are: ICAHN CARL C with ownership of 34,721,118, which is approximately 0% of the company’s market cap and around 2.30% of the total institutional ownership; PAULSON & CO. INC., holding 26,439,035 shares of the stock with an approximate value of $253.02 million in BHC stocks shares; and GOLDENTREE ASSET MANAGEMENT LP, currently with $203.69 million in BHC stock with ownership of nearly 29.107% of the company’s market capitalization.
Positions in Bausch Health Companies Inc. stocks held by institutional investors increased at the end of Thursday and at the time of the Thursday reporting period, where 103 institutional holders increased their position in Bausch Health Companies Inc. [NYSE:BHC] by around 73,694,929 shares. Additionally, 174 investors decreased positions by around 31,639,823 shares, while 57 investors held positions by with 182,994,221 shares. The mentioned changes placed institutional holdings at 288,328,973 shares, according to the latest SEC report filing. BHC stock had 49 new institutional investments in for a total of 13,341,712 shares, while 69 institutional investors sold positions of 11,384,976 shares during the same period.